Back to search
FDAFDA · Food and drugs·Recall number D-0262-2019

Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg, 100-count bottoles, Rx Only, Manufactured for: Northstar Rx LLC Memphis, TN 38141 Manufactured by: Sandoz Inc. Princeton, NJ 08540,NDC 16714-439-01

Published November 21, 2018 · Recall initiated: November 2, 2018

Summary

FDA records drug Class III recall D-0262-2019, published November 21, 2018 and initiated November 2, 2018. Recalling firm: Sandoz Inc; Status: Terminated; Reported quantity: 23053 bottles; Lot: Lot #: JA7319, JA 7320, JA7321, Exp. 03/2020. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cross Contamination with Other Products

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sandoz Inc
Distributor
Nationwide within the United States
Lot
Lot #: JA7319, JA 7320, JA7321, Exp. 03/2020
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg, 100-count bottoles, Rx Only, Manufactured for: Northstar Rx LLC Memphis, TN 38141 Manufactured by: Sandoz Inc. Princeton, NJ 08540,NDC 16714-439-01 recalled?

Yes. FDA published recall D-0262-2019 on November 21, 2018. Reported hazard: Cross Contamination with Other Products

What should I do if I have this product?

Voluntary: Firm initiated · Letter